HomeNewsTrendsEntertainmentSalman Khan’s Radhe launch set to make ‘pay per view’ way to go as COVID wave hurts theatres

Salman Khan’s Radhe launch set to make ‘pay per view’ way to go as COVID wave hurts theatres

Pricing is a crucial factor for the PPV model as industry players say it is very difficult for a critical mass to pay for a single piece of content. Pricing is going to be crucial, and anything more than Rs 100-150 can come across as prohibitive, says one analyst.

May 10, 2021 / 17:31 IST
Story continues below Advertisement
Salman Khan earlier this year had taken to Twitter to announce the theatrical release of Radhe which was a huge relief for exhibitors who are still under pressure due to COVID-19 impact. Image: Radhe will release in theatres on May 13. Twitter
Salman Khan earlier this year had taken to Twitter to announce the theatrical release of Radhe which was a huge relief for exhibitors who are still under pressure due to COVID-19 impact. Image: Radhe will release in theatres on May 13. Twitter

India got its first simultaneous release when Salman Khan Films and Zee Studios, the content vertical of Zee Entertainment, decided to release the big budget Bollywood venture, Radhe, on both pay-per-view platform as well as in theatres.

Radhe, which is scheduled to release on May 13, during the upcoming Eid holiday, will release in theatres worldwide, and will be available to users of over-the-top (OTT) platform Zee5 and will also stream on ZEEPlex, the pay-per-view (PPV) model.

Story continues below Advertisement

Zee is betting big on the latter. But the model is still in its nascent stage in India.

Hence, the company, along with offering Radhe on ZEEPlex for Rs 249 (one-time watch), is also giving access to ZEE5 content for a year at Rs 499 under a combo offer. Through this offer, users will also get access to more than 50 upcoming films across languages and over 40 originals, which are slated to release on ZEE5 this year.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show